Perika

Quick links to important sections

Perika

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Perika

Property Description
Active ingredient Standardized extract of Hypericum perforatum (St John's Wort)
Form Solid oral preparation (tablet or capsule)
Pharmacological class Phytotherapeutic agent, Herbal antidepressant
Common use Supporting emotional well-being and stabilizing mood
Origin Natural, Botanical drug product

What Type of Medicine is Perika?

Perika is classified as a standardized phytotherapeutic agent and an herbal antidepressant, derived from the botanical substance St John's Wort. It is defined as a single-active-ingredient product administered through the oral route, typically formulated as a solid oral preparation. This classification places it within the category of botanical drug products, utilizing a complex plant extract rather than a single synthetic chemical compound. The formulation is clinically recognized for its use in individuals managing low moods associated with daily stressors. Hypericum perforatum extracts are used for symptoms of mild mental stress and exhaustion. This profile establishes its role as an accessible, non-prescription option for those seeking natural support for their emotional well-being.


What is the Composition and General Purpose of Perika?

The core composition of Perika is a standardized extract of the aerial parts of Hypericum perforatum (St John's Wort), primarily utilized for mood support. Standardization is a critical process ensuring that the extract consistently contains specific, measured levels of key components, such as the compounds hypericin and hyperforin. This controlled composition differentiates products like Perika from generic, non-standardized St John's Wort supplements, emphasizing consistency. The mechanism involves a mild modulatory effect on various neurotransmitters, including serotonin, within the central nervous system. Hypericum perforatum extracts are utilized in the management of mild to moderate depression. This indicates that the product helps stabilize mood and provides symptomatic relief for mild to moderate feelings of sadness or temporary nervousness, supporting the body's natural capacity to maintain neurochemical balance. The general purpose is to promote emotional stability and stabilize mood.

Regulatory References

  1. About the National Library of Medicine (NLM)
  2. NLM Review on Hypericum

What side effects are possible with Perika?

Possible Side Effects and Safety Information

The safety profile of Perika, a standardized Hypericum perforatum extract, is officially documented based on regulatory classifications of adverse reactions observed in clinical use. These effects are organized by the physiological system affected.


Frequency-Classified Adverse Reactions

The most frequently observed adverse reactions are categorized as Common (affecting 1 to 10 users in 100) and typically involve Gastrointestinal Disorders, such as dry mouth, nausea, and dyspepsia, along with Nervous System Disorders, including headache and fatigue. Effects categorized as Uncommon (affecting 1 to 10 users in 1,000) include Photosensitivity reactions.


Serious Adverse Reactions and Safety Constraints

Official regulatory documents note the risk of Severe Photosensitivity Reactions, particularly in fair-skinned individuals under intense ultraviolet (UV) exposure. This necessitates a key safety constraint: the avoidance of intense UV sources (e.g., sunbeds or prolonged sunbathing) during the course of use.

Regulatory authorities also document a high-level safety risk regarding concomitant use with many prescription medicines. This is due to the extract's action as an enzyme inducer, which can lead to a reduced therapeutic effect of co-administered drugs or increase the risk of serious adverse reactions, such as the Serotonin Syndrome when combined with other serotonergic agents.


Population and Exposure Considerations

Certain effects, such as anxiety and restlessness, are officially noted as sometimes occurring at the beginning of treatment and may diminish with continued use. Use of the extract is not recommended for children and adolescents under 18 years, or during pregnancy and lactation, due to insufficient safety data.

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information

The official regulatory profile for Perika (Hypericum perforatum extract) focuses on two primary areas of concern in cases of massive over-ingestion and when urgent medical intervention is required.

Documented Overdose Presentations

Overdose Manifestation Exposure Factor
Seizures and confusion Documented after ingestion of massive amounts of the dry extract.
Intensified sunburn-like reactions Risk factor: Exposure to sunlight or UV-light following a massive ingestion.

Required Emergency Actions

In the event of suspected overdose, immediate emergency medical attention must be sought, and you should contact the Poison Help line for guidance.

Supportive Measures: Following a massive dose, regulatory documents explicitly require the patient to be protected from sunlight and all other UV-light sources for 1–2 weeks to mitigate the risk of severe photosensitivity. No specific antidote is officially documented; management is supportive.

Urgent Care Symptoms: Immediate medical help is also required for symptoms such as agitation, hallucinations, fever, fast heart rate, or loss of coordination, especially if the product has been taken with other medicines that affect serotonin levels. These symptoms are recognized in official labeling as signs that require urgent attention.

Therapeutic Uses of Perika

What Perika Treats: Main Uses and Benefits

This standardized botanical extract is commonly used in therapeutic domains involving supportive relief for symptoms related to emotional strain and low mood. The use of this extract is considered relevant within therapeutic domains concerning symptoms associated with temporary mental exhaustion.


Relief for Mild to Moderate Depressive Symptoms

This phytotherapeutic agent is considered relevant across conditions characterized by mild to moderate depressive episodes. It addresses core symptom clusters including persistent low mood, pervasive feelings of sadness, and related loss of interest. This use provides support that helps ease the overall symptom load and may help patients cope more steadily with symptom fluctuations.

Management of Nervous Tension and Emotional Exhaustion

Perika may be part of symptomatic management applied across domains where additional symptomatic support is needed for symptoms related to psychological strain, and is relevant for easing episodes of temporary nervousness and heightened irritability. By easing these manifestations, the product supports general well-being and assists with maintaining functional stability during symptomatic periods.


Quick Fact: Symptomatic Relief

This treatment may be part of symptomatic management applied in clinical settings involving episodic or fluctuating manifestations of mild depression and psychological stress.

Eligibility and Restrictions for Use

The official regulatory profile for Perika (Standardized Hypericum perforatum extract) defines which populations are eligible for use and which are strictly prohibited or restricted based on official documentation from government authorities.

Eligibility Status by Population

Category Regulatory Status
Allowed Age Group Adults and the Elderly (18 years and older).
Use Not Recommended Children and Adolescents (under 18), Pregnant Women, and Breastfeeding Women.
Absolute Contraindication Patients with known hypersensitivity to the extract. Patients taking specific narrow-therapeutic-index drugs, including certain antiretroviral medications, systemic immunosuppressants, and the oral anticoagulant warfarin.

Use is established solely for the adult population. However, the medicine is formally contraindicated for any patient using specific prescription drugs, as officially documented by regulatory bodies, due to the risk of therapeutic failure. Furthermore, use is formally not recommended for minors and women who are pregnant or breastfeeding because sufficient safety data for these populations has not been established. A final condition for eligibility requires the avoidance of intense UV exposure, such as sunbeds or prolonged sun exposure, during the period of use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The most significant and officially documented interactions for Perika (St. John’s Wort, Hypericum perforatum) stem from its ability to induce drug metabolism in the body.

Pharmacokinetic Interactions

Perika is classified as a potent inducer of the CYP3A4 enzyme and the P-glycoprotein (P-gp) drug transporter. This induction leads to a substantial reduction in the blood concentrations of many co-administered medicines, often resulting in therapeutic failure.

Clinically Critical Interactions

Official regulatory information emphasizes that co-administration must be avoided (contraindicated or strongly discouraged) with several essential drug classes due to the risk of reduced efficacy:

  • Immunosuppressants: Such as Cyclosporine and Tacrolimus (risk of organ rejection).
  • HIV/AIDS Medications: Including certain Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors (risk of resistance and virologic failure).
  • Oral Hormonal Contraceptives: (Risk of decreased contraceptive efficacy and breakthrough bleeding).
  • Anticoagulants: Including Warfarin and specific Direct Oral Anticoagulants.

Pharmacodynamic Interactions

Perika may also exert an additive effect when combined with other serotonergic drugs (e.g., SSRIs or SNRIs), potentially leading to excessive levels of serotonin in the central nervous system.

Discontinuation and Monitoring

Due to the time required for enzyme and transporter activity to return to baseline, stopping Perika can cause the blood levels of co-administered drugs to increase, potentially leading to toxicity. Therefore, the official interaction profile requires a period of close monitoring and dose adjustment when Perika use is discontinued.

Mechanism of Action

The mechanism of action for the components in Perika is multi-modal, primarily centering on the modulation of monoamine neurotransmission within the central nervous system. The phloroglucinol derivative hyperforin acts as a non-competitive reuptake inhibitor for the monoamines serotonin, norepinephrine, and dopamine at the synaptic cleft. This interaction effectively increases the concentration of these neurotransmitters in the extracellular space. The reuptake inhibition is mechanistically linked to the activation of the transient receptor potential ion channel TRPC6, which facilitates the influx of sodium and calcium ions into the presynaptic neuron, subsequently altering the transporter's functional status.

Downstream cascades also include an upregulation in the density of postsynaptic 5-HT2 receptors and a downregulation of beta1-adrenoceptors following chronic exposure. Additionally, components demonstrate interaction with gamma-aminobutyric acid (GABAA and GABAB) receptors, which modulates inhibitory neurotransmission. This collective, non-selective modulation of multiple neurotransmitter systems results in systemic physiological changes characterized by altered neurochemical balance.

Dosage and Administration Information

Administration Guidelines for Perika (St. John's Wort Extract)

The following outlines the standardized method of use for Hypericum perforatum L., the active component in Perika.

Administration Scope

The most common route of administration for Perika is oral, typically in the form of a standardized dry extract (tablet or capsule). Certain liquid extracts or oils are also used for cutaneous (topical) administration.

Usage Parameter Standardized Method
Standard Daily Dosing The labeled daily dose for standardized dry extracts generally falls within 600 mg to 1800 mg per day for adults, depending on the specific preparation ratio.
Frequency Dosing may be taken once daily or divided into two to three times daily, based on the product’s specific regimen.
Age Restriction The use of St. John's Wort preparations is not recommended in children and adolescents under 18 years of age due to insufficient available data.

Special Procedural Conditions

Minimum Duration of Use: The beneficial effects of the treatment may be expected within four weeks. A minimum continuous use of at least two to four weeks is often specified to see the full effect.

UV Light Restriction: During the entire course of treatment, users are instructed to avoid intense UV-exposure, including strong sunlight or sunbeds, as the medication may increase photosensitivity.

These instructions define the method of administration, including the total daily dose and procedural constraints, to ensure the medicine is used in accordance with standardized specifications.

Recent Clinical Evidence

Research evidence / Overview of Studies for Perika

The research for standardized extracts of Hypericum perforatum (St John's Wort), such as Perika, was studied for use in mood support and was evaluated in numerous systematic reviews and meta-analyses. This summary focuses strictly on what has been observed in clinical settings and what the current scientific literature reports, without offering clinical advice or treatment recommendations.


Evidence for Use in Mild to Moderate Depressive Episodes

The most comprehensive research body for standardized extracts was studied for use in adults experiencing mild to moderate depressive episodes. The primary evidence comes from reviews of Randomized Controlled Trials (RCTs), where the extract was evaluated in comparison to both an inactive placebo and various conventional pharmaceutical antidepressants.

Researchers examined changes in the severity of symptoms, primarily utilizing standardized measurement tools such as the Hamilton Depression Rating Scale (HAM-D). Studies reported patterns in which the measured changes in HAM-D scores for the extract group were distinct from the measured changes reported for the placebo group.

Studies explored how the extract compared to pharmaceutical comparators, and findings were mixed regarding measured outcomes. Evidence quality varies across different trials and preparations.


Evidence for Traditional Use in Nervous Tension and Emotional Exhaustion

For less-severe symptoms like nervous tension and general emotional exhaustion, research examined these conditions mainly through the documentation of Traditional Use, as compiled by regulatory bodies for milder, non-clinical uses. Studies often involve patient-reported outcomes describing perceived discomfort, rather than using highly specific clinical scales. Research provides insight into how individuals reported their experiences during periods of temporary psychological strain.


What Remains Uncertain and Areas for Future Research

Scientific reviews indicate several areas where certainty remains low in the evidence base. Long-term effects are not fully established, requiring further research exploring responses over defined time intervals beyond the current short-term trial limits. Furthermore, evidence is limited concerning populations with more severe, complex, or acute depressive episodes.

Key Studies & References

  1. St. John's Wort - StatPearls (Source for general background and lack of FDA approval)

Frequently Asked Questions (FAQ)

Common questions about Perika (FAQ)

Q: How quickly can someone expect to feel the effects of Perika?

According to official administration guidelines, the beneficial effects of Perika may be expected within four weeks of continuous use. A minimum duration of at least two to four weeks is often specified to start seeing the full effect.

Q: Can elderly people generally take Perika?

Perika is intended for use by adults and the elderly (individuals 18 years and older). Regulatory bodies advise caution and close monitoring for potential drug interactions in adults over age 65, as this population may be more susceptible to such effects.

Q: Can people with liver or kidney issues use Perika?

Official product information does not explicitly prohibit use for individuals with liver or kidney impairment. Since the extract affects key systems that process drugs in the liver and kidneys (CYP3A4/P-gp), individualized guidance from a healthcare provider is recommended regarding specific health conditions.

Q: Does Perika need to be taken with food?

Product instructions vary, but generally, there is no strict requirement that Perika must be taken with a meal. Examples in medical literature indicate it can be taken with water or with meals. Consistency in administration is a general principle often referenced in usage guidelines.

Q: Are there specific times of day that are best for taking Perika?

Official administration guidelines state that dosing may be taken once daily or divided into two to three times daily, depending on the specific product regimen. There is no official restriction advising a specific time, such as morning versus evening.

Q: Can Perika affect sleep patterns?

The nervous system effects noted include restlessness and trouble sleeping, which are listed as possible side effects. Official regulatory documents list these reactions among the potential adverse events.

Q: Is Perika safe for people with high blood pressure?

While not an absolute contraindication, hypertensive crisis is reported as a rare, severe side effect. Official information generally suggests caution when using any supplements in individuals with cardiovascular disorders.

Q: Is it safe to take Perika if I have a history of bipolar disorder?

Use of Perika in individuals with bipolar disorder carries specific risk considerations. Medical reports suggest that in some cases, St. John's Wort may potentially bring on mania or speed up the cycling between depressive and manic episodes.

Q: How is the quality of Perika regulated?

In the United States, Perika is regulated as a dietary supplement by the FDA. The FDA regulates it as a dietary supplement, which involves a different regulatory pathway compared to pharmaceutical drugs.

Q: Does Perika have a sedating effect?

Sedating effects are not explicitly listed among the common adverse reactions. However, fatigue and dizziness are noted as possible side effects that a user might experience, based on official product information.

Q: Is there any research on Perika for seasonal changes in mood?

Research has explored the use of St. John's Wort extracts for Seasonal Affective Disorder (SAD). However, official research reviews indicate that the evidence for its effectiveness in this specific area remains mixed.

Q: Can Perika be crushed or should it be swallowed whole?

Instructions for hard capsule preparations generally advise that the whole capsule should be swallowed with water. Crushing or opening the capsule is typically not recommended unless specific product instructions state otherwise.

Q: How long does it take for Perika to clear out of the system?

A period of at least two weeks is generally noted as the time required for the long-acting constituents and the enzyme-inducing effects of the extract to clear from the body before starting certain other medications. This is known as a washout period.

Q: Is Perika safe for people with a history of seizures?

There is a theoretical risk that Perika could reduce the blood levels of certain anti-seizure medications (anticonvulsants). This risk indicates the need for clinical monitoring when used concurrently with anticonvulsant medications.

Q: Does Perika interact with thyroid medication?

Yes, Perika can interact with thyroid medications, such as levothyroxine. The extract can increase how quickly the body breaks down these drugs, potentially leading to decreased therapeutic efficacy.

Q: What happens if you stop taking Perika suddenly?

Unlike some prescription antidepressants, St. John's Wort generally does not require a gradual dose reduction and can be stopped abruptly without leading to withdrawal syndrome. However, any cessation of use should involve consideration of concomitant medications, particularly before surgery or when starting a new prescription drug.

Q: Can Perika cause changes in appetite or weight?

Direct causation of weight gain has not been established in studies. If appetite was initially decreased due to feelings of sadness or low mood, an improvement in these symptoms may lead to an increase in appetite and subsequent weight changes.

Q: Are there any restrictions on physical activity while taking Perika?

The primary restriction relates to sun exposure. Users are instructed to avoid intense UV-exposure, including strong sunlight or sunbeds, due to the potential for increased photosensitivity. No other restrictions on general physical activity are cited in official documentation.

Q: Can Perika be used for general 'nerve health' or nervous disorders?

Historically, the herb has been used for 'nervous disorders.' Contemporary regulatory bodies recognize its traditional use in treating symptoms of mild mental stress and nervous tension.

Q: Is Perika safe for teenagers?

Due to insufficient available data and safety considerations in this age group, the extract is officially not recommended for use in children and adolescents under 18 years of age.

Q: What are the active compounds thought to be responsible for Perika's effects?

The overall extract is considered the active substance, as multiple compounds are thought to contribute to the effect. The most extensively studied key components are the phloroglucinol derivative hyperforin, and the naphthodianthrones hypericin and pseudohypericin.

Q: Can Perika affect blood clotting?

Perika is known to interact significantly with certain oral anticoagulant medicines, such as Warfarin, reducing their effects. This demonstrates an indirect influence on the bodily systems responsible for the clotting cascade, and monitoring is typically part of the regimen when used with these types of drugs.

Q: Are there specific laboratory tests that can be affected by Perika?

Yes, Perika can interfere with certain laboratory tests. For example, interference has been reported in specific immunoassays used to measure concentrations of the heart drug digoxin.

How should Perika be stored and disposed of?

The official regulatory requirements for storing and disposing of Perika, a standardized Hypericum perforatum extract, focus on maintaining the product's stability and ensuring environmental safety.

Mandatory Storage Conditions

Storage Requirement Official Regulatory Statement
Temperature and Light Store in a cool, dry place, protected from direct sunlight and heat sources (typically below 25 C).
Packaging Keep the container tightly closed and preserve the product in its container of origin.
Child Safety Keep out of reach of children (Precautionary Statement P102).

Official Disposal Rules

Expired or unused medicine must be handled in compliance with local regulations by authorized companies. It is strictly prohibited to discharge the product into drains, sewers, or environmental waterways to prevent contamination, as defined by environmental regulatory protocols.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Perika found in:

A-Z Index: